The FDA has issued a Complete Response Letter for ITM-11, [...]

Adneuris Therapeutics has granted Maruishi Pharmaceutical exclusive rights to develop [...]

AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]

AB2 Bio will receive $30 million from Nippon Shinyaku after [...]

PolyPid’s D-PLEX100 has been granted FDA Priority Review following acceptance [...]

Telix has dosed the first patient in a Phase 3 [...]

The European Medicines Agency (EMA) has accepted Almirall’s application to [...]

Adneuris Therapeutics has granted Zhejiang Conba Pharmaceutical exclusive rights to [...]

The European Commission has approved Erbitux (cetuximab) in combination with [...]

Merck has received FDA Breakthrough Therapy designation for enpatoran, an [...]